Tularemia: The disease and the weapon

Dermatologic Clinics

Volumn 22, Issue 3, 2004, Pages 313-320

  Cronquist, Steven D ^a  

^a NAVAL HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTIC AGENT; BETA LACTAM ANTIBIOTIC; CHLORAMPHENICOL; CIPROFLOXACIN; GENTAMICIN; LEVOFLOXACIN; MACROLIDE; QUINOLONE DERIVATIVE; STREPTOMYCIN; TETRACYCLINE;

ANTHRAX; ANTIBIOTIC THERAPY; ANTIGEN DETECTION; BACTERIAL INFECTION; BIOLOGICAL WARFARE; BOTULISM; CULTURE TECHNIQUE; DIAGNOSTIC TEST; DIFFERENTIAL DIAGNOSIS; FLUORESCENT ANTIBODY TECHNIQUE; FRANCISELLA TULARENSIS; HEMATOCRIT; HEMOGLOBIN DETERMINATION; HISTOLOGY; HUMAN; IMMUNOBLOTTING; LEUKOCYTE DIFFERENTIAL COUNT; LEUKOCYTOSIS; MORBIDITY; NONHUMAN; PARASITE VECTOR; PLAGUE; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PUBLIC HEALTH SERVICE; PULSED FIELD GEL ELECTROPHORESIS; RECURRENCE RISK; REVIEW; SKIN ULCER; SMALLPOX; THORAX RADIOGRAPHY; THROMBOCYTE COUNT; TREATMENT FAILURE; TULAREMIA; VIRUS HEMORRHAGIC FEVER;

ANIMALS; ANTI-BACTERIAL AGENTS; BACTERIAL VACCINES; BIOLOGICAL WARFARE; FEMALE; FRANCISELLA TULARENSIS; HUMANS; MALE; PROGNOSIS; RISK ASSESSMENT; TULAREMIA; UNITED STATES; VACCINATION;

EID: 2942659070     PISSN: 07338635     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.det.2004.03.009     Document Type: Review

References (55)

1. Francis E. Tularemia: a new disease of man. JAMA. 78:1922;1015-1018
2. Choi E. Tularemia and Q fever. Med Clin North Am. 86(2):2002;393-416
3. Jacobs R.F. Tularemia. Adv Pediatr Infect Dis. 12:1996;55-69
4. Dennis D.T., Inglesby T.V., Henderson D.A., Bartlett J.G., Ascher M.S., Eitzen E., et al. Tularemia as a biological weapon: medical and public health management. JAMA. 285(21):2001;2763-2773
5. Darling R.G., Catlett C.L., Huebner K.D., Jarrett D.G. Threats in bioterrorism I: CDC category A agents. Emerg Med Clin North Am. 20(2):2002;273-309
6. Markowitz L.E., Hynes N.A., de la Cruz P., Campos E., Barbaree J.M., Plikaytis B.D., et al. Tick-borne tularemia. JAMA. 254:1985;2922-2925
7. McCrumb F.R. Jr., Snyder M.J., Woodward T.E. Studies on human infection with Pasteurella tularensis: comparison of streptomycin and chloramphenicol in the prophylaxis of clinical disease. Trans Assoc Am Physicians. 70:1957;74-80
8. Hornick R. Tularemia revisited. N Engl J Med. 345(22):2001;1637-1639
9. Uhari M., Syrjala H., Salminen A. Tularemia in children caused by Francisella tularensis biovar palaearctica. Pediatr Infect Dis J. 9:1990;80-83
10. Schmid G.P., Kornblatt A.N., Conners C.A., Patton C., Carney J., Hobbs J., et al. Clinically mild tularemia associated with tick-borne Francisella tularensis. J Infect Dis. 148:1983;63-67
11. Langley R., Campbell R. Tularemia in North Carolina, 1965-1990. N C Med J. 56:1995;314-317
12. Feldman K.A., Enscore R.E., Lathrop S.L., Matyas B.T., McGuill M., Schriefer M.E., et al. An outbreak of primary pneumonic tularemia on Martha's Vineyard. N Engl J Med. 345(22):2001;1601-1606
13. Jellison W.L., Epler D.C., Kuhns E., Kohls G.M. Tularemia in man from a domestic rural water supply. Public Health Rep. 65:1950;1219-1226
14. Berdal B.P., Mehl R., Haaheim H., Loksa M., Grunow R., Burans J., et al. Field detection of Francisella tularensis. Scand J Infect Dis. 32(3):2000;287-291
15. Eliasson H., Lindback J., Nuorti J.P., Arneborn M., Giesecke J., Tegnell A. The 2000 tularemia outbreak: a case-control study of risk factors in disease-endemic and emergent areas, Sweden. Emerg Infect Dis. 8(9):2002;956-960
16. Reintjes R., Dedushaj I., Gjini A., Jorgensen T.R., Cotter B., Lieftucht A., et al. Tularemia outbreak investigation in Kosovo: case control and environmental studies. Emerg Infect Dis. 8(1):2002;69-73
17. Young L.S., Bicknell D.S., Archer B.G., Clinton J.M., Leavens L.J., Feeley J.C., et al. Tularemia epidemic: Vermont, 1968. Forty-seven cases linked to contact with muskrats. N Engl J Med. 280:1969;1253-1260
18. Singh-Behl D., La Rosa S.P., Tomecki K.J. Tick-borne infections. Dermatol Clin. 21(2):2003;237-244
19. Saliba G.S., Harmston F.C., Diamond B.E., Zymet C.L., Goldenberg M.I., Chin T.D.Y. An outbreak of human tularemia associated with the American dog tick, Dermacentor variabilis. Am J Trop Med Hyg. 15:1966;531-538
20. McGinley-Smith D.E., Tsao S.S. Dermatoses from ticks. J Am Acad Dermatol. 49(3):2003;363-392
21. Jacobs R.F., Narain J.P. Tularemia in children. Pediatr Infect Dis. 2:1983;487-491
22. From the Centers for Disease Control and Prevention Tularemia-United States, 1990-2000. JAMA. 287(12):2002;1519-1520
23. Croddy E., Krcalova S. Tularemia, biological warfare, and the battle for Stalingrad (1942-1943). Mil Med. 166(10):2001;837-838
24. Alibek K. Biohazard. 1999;29-38 Random House, New York
25. Harris S. Japanese biological warfare research on humans: a case study of microbiology and ethics. Ann NY Acad Sci. 666:1992;21-52
26. Franz D.R., Jahrling P.B., Friedlander A.M., McClain D.J., Hoover D.L., Bryne W.R., et al. Clinical recognition and management of patients exposed to biological warfare agents. JAMA. 278(5):1997;399-411
27. Mintz J. US provides a peek at air sensor program. Washington Post. November 15:2003;A03
28. McGovern T.W., Christopher G.W., Eitzen E.M. Cutaneous manifestations of biological warfare and related threat agents. Arch Dermatol. 135(3):1999;311-322
29. Rodgers B.L., Duffield R.P., Taylor T., Jacobs R.F., Schutze G.E. Tularemic meningitis. Pediatr Infect Dis J. 17(5):1998;439-441
30. LeDoux M.S. Tularemia presenting with ataxia. Clin Infect Dis. 30(1):2000;211-212
31. Jacobs R.F., Condrey Y.M., Yamauchi T. Tularemia in adults and children: a changing presentation. Pediatrics. 76:1985;818-822
32. Cerny Z. Skin manifestations of tularaemia. Int J Dermatol. 54:1994;279
33. Peter R., Banyai T. Erythema nodosum revealing oculoglandular tularemia. Dermatology. 202:2001;79-80
34. Ruiz A.I., Gonzalez A., Miranda A., Torrero V., Gutierrez C., Garcia M. Sweet's syndrome associated with francisella tularensis infection. Int J Dermatol. 40(12):2001;791-793
35. Guerrant R.L., Humphries M.K., Butler J.E., Jackson R.S. Tick-borne oculoglandular tularemia. Arch Intern Med. 136:1976;811-813
36. Steinemann T.L., Sheikholeslami M.R., Brown H.H., Bradsher R.W. Oculoglandular tularemia. Arch Ophthalmol. 117(1):1999;132-133
37. Ketai L., Alrahji A.A., Hart B., Enria D., Mettler F. Jr. Radiologic manifestations of potential bioterrorist agents of infection. Am J Roentgenol. 180(3):2003;565-575
38. Rubin S.A. Radiographic spectrum of pleuropulmonary tularemia. Am J Roentgenol. 131:1978;277-281
39. Bevanger L., Macland J.A., Naess A.I. Agglutinins and antibodies to Francisella tularensis outer membrane antigens in the early diagnosis of disease during an outbreak of tularemia. J Clin Microbiol. 26:1988;433-437
40. Karhukorpi E.K., Karhukorpi J. Rapid laboratory diagnosis of ulceroglandular tularemia with polymerase chain reaction. Scand J Infect Dis. 33(5):2001;383-385
41. Junhui Z., Ruifu Y., Jianchun L., Songle Z., Meiling C., Fengxiang C., et al. Detection of Francisella tularensis by the polymerase chain reaction. J Med Microbiol. 45(6):1996;477-482
42. Robinson-Dunn B. The microbiology laboratory's role in response to bioterrorism. Arch Pathol Lab Med. 126(3):2002;291-294
43. Weedon D. Skin pathology. 2nd edition:2002;636 Churchill Livingstone, London
44. From the Centers for Disease Control and Prevention Recognition of illness associated with the intentional release of a biologic agent. JAMA. 286(17):2001;2088-2090
45. Werchniak A.E., Herfort O.P., Farrell T.J., Connolly K.S., Baughman R.D. Milker's nodule in a healthy young woman. J Am Acad Dermatol. 49(5):2003;910-911
46. Kostman J.R., DiNubile M.J. Nodular lymphangitis: a distinctive but often unrecognized syndrome. Ann Intern Med. 118:1993;883-888
47. Russell P., Eley S.M., Fulop M.J., Bell D.L., Titball R.W. The efficacy of ciprofloxacin and doxycycline against experimental tularaemia. J Antimicrob Chemother. 41(4):1998;461-465
48. Aranda E.A. Treatment of tularemia with levofloxacin. Clin Microbiol Infect. 7(3):2001;167-168
49. Patt H.A., Feigin R.D. Diagnosis and management of suspected cases of bioterrorism: a pediatric perspective. Pediatrics. 109(4):2002;685-692
50. Johansson A., Berglund L., Gothefors L., Sjostedt A., Tarnvik A. Ciprofloxacin for treatment of tularemia in children. Pediatr Infect Dis J. 19(5):2000;449-453
51. Sawyer W.D., Dangerfield H.G., Hogge A.L., Crozier D. Antibiotic prophylaxis and therapy of airborne tularemia. Bacteriol Rev. 30:1966;542-548
52. Chen W., Shen H., Webb A., KuoLee R., Conlan J.W. Tularemia in BALB/c and C57BL/6 mice vaccinated with Francisella tularensis LVS and challenged intradermally, or by aerosol with virulent isolates of the pathogen: protection varies depending on pathogen virulence, route of exposure, and host genetic background. Vaccine. 8:21(25-26):2003;3690-3700
53. Nersesyan A.K. Vaccines against dangerous infections and cancer. Lancet Oncol. 3(6):2002;331
54. Ellis J., Oyston P.C., Green M., Titball R.W. Tularemia. Clin Microbiol Rev. 15(4):2002;631-646
55. Cox S.K., Everett E.D. Tularemia: an analysis of 25 cases. Mo Med. 78:1981;70-74